Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2006 3
2008 3
2010 1
2011 1
2012 2
2013 2
2014 5
2015 4
2016 3
2017 2
2018 7
2019 9
2020 7
2021 7
2022 10
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean isoda casanova (1 results)?
Protein-driven nanomedicines in oncotherapy.
Casanova I, Unzueta U, Arroyo-Solera I, Céspedes MV, Villaverde A, Mangues R, Vazquez E. Casanova I, et al. Curr Opin Pharmacol. 2019 Aug;47:1-7. doi: 10.1016/j.coph.2018.12.004. Epub 2019 Jan 25. Curr Opin Pharmacol. 2019. PMID: 30685732 Review.
Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles.
Martínez-Torró C, Alba-Castellón L, Carrasco-Díaz LM, Serna N, Imedio L, Gallardo A, Casanova I, Unzueta U, Vázquez E, Mangues R, Villaverde A. Martínez-Torró C, et al. Among authors: casanova i. Biomed Pharmacother. 2023 Aug;164:114976. doi: 10.1016/j.biopha.2023.114976. Epub 2023 Jun 3. Biomed Pharmacother. 2023. PMID: 37276641 Free article.
High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles.
Voltà-Durán E, Alba-Castellón L, Serna N, Casanova I, López-Laguna H, Gallardo A, Sánchez-Chardi A, Villaverde A, Unzueta U, Vázquez E, Mangues R. Voltà-Durán E, et al. Among authors: casanova i. Acta Biomater. 2023 Oct 15;170:543-555. doi: 10.1016/j.actbio.2023.09.001. Epub 2023 Sep 6. Acta Biomater. 2023. PMID: 37683965 Free article.
Artificial Inclusion Bodies for Clinical Development.
Sánchez JM, López-Laguna H, Álamo P, Serna N, Sánchez-Chardi A, Nolan V, Cano-Garrido O, Casanova I, Unzueta U, Vazquez E, Mangues R, Villaverde A. Sánchez JM, et al. Among authors: casanova i. Adv Sci (Weinh). 2019 Nov 27;7(3):1902420. doi: 10.1002/advs.201902420. eCollection 2020 Feb. Adv Sci (Weinh). 2019. PMID: 32042562 Free PMC article.
Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs.
Sánchez-García L, Serna N, Álamo P, Sala R, Céspedes MV, Roldan M, Sánchez-Chardi A, Unzueta U, Casanova I, Mangues R, Vázquez E, Villaverde A. Sánchez-García L, et al. Among authors: casanova i. J Control Release. 2018 Mar 28;274:81-92. doi: 10.1016/j.jconrel.2018.01.031. Epub 2018 Jan 31. J Control Release. 2018. PMID: 29408658
Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticles.
Voltà-Durán E, Serna N, Sánchez-García L, Aviñó A, Sánchez JM, López-Laguna H, Cano-Garrido O, Casanova I, Mangues R, Eritja R, Vázquez E, Villaverde A, Unzueta U. Voltà-Durán E, et al. Among authors: casanova i. Acta Biomater. 2021 Jan 1;119:312-322. doi: 10.1016/j.actbio.2020.11.018. Epub 2020 Nov 12. Acta Biomater. 2021. PMID: 33189955
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery.
Serna N, Pallarès V, Unzueta U, Garcia-Leon A, Voltà-Durán E, Sánchez-Chardi A, Parladé E, Rueda A, Casanova I, Falgàs A, Alba-Castellón L, Sierra J, Villaverde A, Vázquez E, Mangues R. Serna N, et al. Among authors: casanova i. J Control Release. 2022 Mar;343:277-287. doi: 10.1016/j.jconrel.2022.01.017. Epub 2022 Jan 17. J Control Release. 2022. PMID: 35051493
60 results